IgM, but not IgA rheumatoid factor interferes with anti-cardiolipin and anti-β2 glycoprotein i measurements: A quantitative analysis

Lupus

Volumn 20, Issue 6, 2011, Pages 614-619

  Lakos, G ^a   Teodorescu, M ^a  

^a TheraTest Laboratories   (United States)

Author keywords

anti cardiolipin antibody; IgA; IgM; interference; rheumatoid factor

Indexed keywords

BETA2 GLYCOPROTEIN 1 ANTIBODY; CARDIOLIPIN ANTIBODY; IMMUNOGLOBULIN A; IMMUNOGLOBULIN M; PHOSPHOLIPID ANTIBODY; RHEUMATOID FACTOR;

ARTICLE; CROSS REACTION; FALSE POSITIVE RESULT; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS;

ANTIBODIES, ANTICARDIOLIPIN; ANTIBODIES, ANTIPHOSPHOLIPID; ANTIPHOSPHOLIPID SYNDROME; BETA 2-GLYCOPROTEIN I; CROSS REACTIONS; FALSE POSITIVE REACTIONS; HUMANS; IMMUNOASSAY; IMMUNOGLOBULIN A; IMMUNOGLOBULIN M; RHEUMATOID FACTOR;

EID: 79956149156     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203310393379     Document Type: Article

References (18)

1. Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006 ; 4: 295-306
2. Galli M, Luciani D, Bertolini G, Barbui T. Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature. Blood. 2003 ; 101: 1827-1832 (Pubitemid 36237580)
3. Wong RC, Gillis D, Adelstein S, et al. Consensus guidelines on anti-cardiolipin antibody testing and reporting. Pathology. 2004 ; 36: 63-68 (Pubitemid 38223415)
4. Wong RC, Favaloro EJ, Adelstein S, et al. Consensus guidelines on anti-beta 2 glycoprotein I testing and reporting. Pathology. 2008 ; 40: 58-63 (Pubitemid 350172955)
5. Pierangeli SS, Harris EN. A protocol for determination of anticardiolipin antibodies by ELISA. Nat Protoc. 2008 ; 3: 840-848 (Pubitemid 351639028)
6. Tincani A, Allegri F, Balestrieri G, et al. Minimal requirements for antiphospholipid antibodies ELISAs proposed by the European Forum on Antiphospholipid Antibodies. Thromb Res. 2004 ; 114: 553-558 (Pubitemid 39422591)
7. Abo SM, DeBari VA. Laboratory evaluation of the antiphospholipid syndrome. Ann Clin Lab Sci. 2007 ; 37: 3-14
8. Devreese K, Hoylaerts MF. Challenges in the diagnosis of the antiphospholipid syndrome. Clin Chem. 2010 ; 56: 930-940
9. Galperin I, Fortin PR, Subang R, Newkirk MM, Rauch J. A subset of rheumatoid factors crossreacts with cardiolipin in patients positive for IgM rheumatoid factor and anticardiolipin antibodies. J Rheumatol. 2000 ; 27: 820-821 (Pubitemid 30151373)
10. Agopian MS, Boctor FN, Peter JB. False-positive test result for IgM anticardiolipin antibody due to IgM rheumatoid factor. Arthritis Rheum. 1988 ; 31: 1212-1213
11. Martín BB, Marquet P, Ferrer JM, et al. Rheumatoid factor interference in a tacrolimus immunoassay. Ther Drug Monit. 2009 ; 31: 743-745
12. Berth M, Bosmans E, Everaert J, et al. Rheumatoid factor interference in the determination of carbohydrate antigen 19-9 (CA 19-9). Clin Chem Lab Med. 2006 ; 44: 1137-1139 (Pubitemid 44370937)
13. Després N, Grant AM. Antibody interference in thyroid assays: a potential for clinical misinformation. Clin Chem. 1998 ; 44: 440-454 (Pubitemid 28141337)
14. Danowski A, de Azevedo MN, de Souza Papi JA, Petri M. Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus. J Rheumatol. 2009 ; 36: 1195-1199
15. Swadźba J, Iwaniec T, Szczeklik A, Musiał J. Revised classification criteria for antiphospholipid syndrome and the thrombotic risk in patients with autoimmune diseases. J Thromb Haemost. 2007 ; 5: 1883-1889 (Pubitemid 47288946)
16. Fanopoulos D, Teodorescu MR, Varga J, Teodorescu M. High frequency of abnormal levels of IgA anti-beta2-glycoprotein I antibodies in patients with systemic lupus erythematosus: relationship with antiphospholipid syndrome. J Rheumatol. 1998 ; 25: 675-680 (Pubitemid 28212374)
17. Lakos G, Kiss E, Regëczy N, et al. Isotype distribution and clinical relevance of anti-beta2-glycoprotein I (beta2-GPI) antibodies: Importance of IgA isotype. Clin Exp Immunol. 1999 ; 117: 574-579 (Pubitemid 29398308)
18. Tsutsumi A, Matsuura E, Ichikawa K, Fujisaku A, Mukai M, Koike T. IgA class anti-beta2-glycoprotein I in patients with systemic lupus erythematosus. J Rheumatol. 1998 ; 25: 74-78 (Pubitemid 28060121)